Top

Journal of Public Health

Published in:

01-06-2009 | Original Article

Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status

Authors: Thomas Elkeles, Wolf Kirschner, Christian Graf, Petra Kellermann-Mühlhoff

Published in: Journal of Public Health | Issue 3/2009

Abstract

Aim

The Disease Management Programmes (DMPs) introduced in Germany since 2003 are intended to improve health care for the chronically ill. Whether they do this is currently being investigated in various evaluation settings. In order to assess possible changes in the process quality from the point of view of patients, the BARMER health insurance company conducted a national postal survey in Germany in 2007 of its customers with diabetes mellitus type 2 in order to compare programme participants and non-participants. This evaluation is a sub-analysis intended to clarify whether the utilisation, acceptability and perceived benefits of the programme differ as a result of educational status.

Subjects and Methods

A nationally representative random sample was drawn from BARMER insurance customers with type 2 diabetes, aged 45–79 years. Questionnaires were evaluated from 38.5% of the sample (DMP-participant respondents: n = 2,158; non-participant respondents: n = 2,182).

Results

A lower educational status was related among other things with increased morbidity, a poorer level of information and also a less well-developed “preventive attitude” to the disease. The finding that 49% of participants had a higher school qualification compared with 45% of non-participants, although significant, is less pronounced than the differences found between DMP participants and non-participants for other values analysed. A social influence could be found concerning the differences in treatment provided within the programme. A multivariate analysis shows that both the participation in the programme and higher levels of education have independent positive effects on the satisfaction with health status, with the effect of programme participation being stronger.

Conclusions

It can be assumed that the clear differences established between the groups of DMP participants and non-participants can in no way be explained solely by the comparatively small difference related to school education. Patients obviously appreciate the fact that the health personnel and the insurance company are paying increased interest to their disease, and this is true to an increased degree for participants with only basic schooling. Although overall this group is significantly under-represented among the participants, they reported to an increased degree that they were profiting from the programme.

Standard instruments for evaluating health-related quality of life, such as SF 12 or SF 36 (Bullinger and Morfeld 2004), are not specifically designed with diabetes in mind. With no validated standards for diabetes-specific instruments (cf. Hirsch 1996, Altenhofen et al. 2005), items were included that were tailored to diabetes type 2.

In addition, another type of standardisation was tested according to age and gender. Assuming that non-participants and participants would be similar in terms of both age and gender structure (which is not in fact the real situation, but which leads to full control of these factors), the non-participants were standardised separately to the participants for gender according to age. This led to slightly different values for proportions behind the decimal point without influencing the significance values determined.

Altenhofen L, Hagen B, Hass W (2005) Aspekte der Lebensqualität älterer Typ 2-Diabetiker-Ergebnisse aus einer Patientenbefragung unter Teilnehmern der Diabetes-Strukturvereinbarungen Nordrhein. In: Badura B, Iseringhausen O (eds) Wege aus der Krise der Versorgungsorganisation. Beiträge aus der Versorgungsforschung. Hans Huber Verlag, Bern, pp 238–254

Altenhofen L, Hagen B, Hass W (2006) DMP Diabetes mellitus Typ 2-Was zeigen die bisherigen Ergebnisse aus Nordrhein? http://www.zi-berlin.de/dmp/downloads.php (08.03.2008)

Blumenstock G, Matziou P, Weigel I, Selbmann H-K (2006) Beschreibung der Diabetiker-Versorgung aus Patientensicht-Befragungsergebnisse im Diabetes-Modellvorhaben Südwürttemberg. Diabetes und Stoffwechsel 1(3):173–180CrossRef

Bullinger M, Morfeld M (2004) Der Health Survey SF-36/SF-12: Darstellung und aktuelle Entwicklungen. In: Maurischat C, Morfeld M, Kohlmann T, Bullinger M, eds Lebensqualität: Nützlichkeit und Psychometrie des Health Survey SF-36/SF-12 in der medizinischen Rehabilitation. Pabst, Lengerich, pp 15–27

Busse R (2004) Disease Management programs in Germany’s statutory health insurance system. Health Aff 23(3):56–67CrossRef

Dunkelberg S, Zingel D, Noack A, van den BH, Kaduszkiewitz H (2006) Welche Patienten werden (nicht) in das DMP Diabetes eingeschlossen? Gesundheitswesen 68:289–293PubMedCrossRef

Eichenlaub A, Steiner M (2005) Verbesserte Diabetikerversorgung in Sachsen-Anhalt. Ergebnisse der Evaluation des Diabetes Modellprojektes (1. Quartal 2001 bis 4. Quartal 2002). Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 99(3):191–195

Eller M, Satzinger W, Holle R, Meisinger C, Thorand B (2005) Disease-Management-Programme in Deutschland: Erste Reaktionen der Diabetiker. Gesundheitswesen 67, Special Issue 1:144–149

Elkeles T, Heinze S, Eifel R (2007) Healthcare by a DMP for Diabetes mellitus Type 2-Results of a survey of participating insurance customers of a health insurance company in Germany. J Publ Health 15(6):473–80CrossRef

Elkeles T, Kirschner W, Graf C, Kellermann-Mühlhoff P (2008) Versorgungsunterschiede zwischen DMP und Nicht-DMP aus Sicht der Versicherten. Ergebnisse einer vergleichenden Versichertenbefragung von Typ 2-Diabetikern der BARMER. Gesundheits- und Sozialpolitik 62(1):10–18

Faller H (2006) Patientenorientierung im Gesundheitswesen: Arzt-patient-beziehung, shared decision making, empowerment. In: Pawils S, Koch U (eds) Psychosoziale Versorgung in der Medizin. Entwicklungstendenzen und Ergebnisse der Versorgungsforschung. Schattauer, Stuttgart, pp 74–84

Gerlach FM, Beyer M, Szecsenyi J, Raspe H (2003) Evaluation von Disease-Management-Programmen-Aktuelle Defizite, Anforderungen, Methoden. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 97:495–501

Graf C (2006) Disease Management Programme und Integrierte Versorgung. Gesundheits- und Sozialpolitik 60(5–6):42–52

Graf C, Ullrich W, Marschall U (2008) Nutzenbewertung der DMP Diabetes mellitus? Neue Erkenntnisse aus dem Vergleich von DMP-Teilnehmern und Nichtteilnehmern anhand von GKV-Routinedaten und einer Patientenbefragung. Gesundheits- und Sozialpolitik 62(1):19–30

Grogan S, Conner M, Norman P, Willits D, Porter I (2000) Validation of a questionnaire measuring patient satisfaction with general practitioner services. Qual Health Care 9:210–215PubMedCrossRef

Hall JA, Dornan MC (1988) Meta-analysis of satisfaction with medical care: description of research domain and analysis of overall satisfaction levels. Soc Sci Med 27(6):637–644PubMedCrossRef

Häussler B, Wille E, Wasem J, Storz P (2005) Diabetiker im Disease Management. Erste Erkenntnisse über die Wirkung der Disease Management Programme in der gesetzlichen Krankenversicherung. Gesundheits- und Sozialpolitik 59(9–10):23–33

Hirsch A (1996) Diabetes und Lebensqualität. In: Petermann F (ed) Lebensqualität und chronische Krankheit. Dustri, München, pp 185–222

Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J (2005) ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct-a study protocol. BMC Public Health 5:99PubMedCrossRef

Knight K, Badamgarav E, Henning JM, Hasselblad V, Gano AD Jr, Ofman JJ, Weingarten SR (2005) A systematic review of diabetes disease management programs. Am J Manag Care 11(4):242–250PubMed

Lippmann-Grob B, Bierwirth RA, Kron P, Leinhos B, Funke K, Huptas M, Grüneberg M, Weich KW, Münscher C, Potthoff F (2003) Patientenklassifikation und Risikoprofilanalysen bei Typ-2-Diabetikern in der Schwerpunktpraxis. Ergebnisse der TEMPO-Studie. Deut Med Wochenschr 129:75–81CrossRef

Lippmann-Grob B, Hillenbrand H, Kolonko B, Vogelmann M (2006) Diabetikerversorgung in Baden-Württemberg. Messung der Versorgungsqualität mittels Patientenbefragung im Rahmen des Projektes “Regionale Versorgungsqualität der Arbeitsgemeinschaft Diabetologie Baden-Württemberg (ADBW)”. Diabetes, Stoffwechsel und Herz 15(1):21–28

Miksch A, Hermann K, Trieschmann J, Roelz A, Heiderhoff M, Laux G, Rosemann T, Szeczenyi J (2008) Gender-specific differences in quality of life of patients with type 2 diabetes with or without participating in DMP. Gesundheitswesen 70:250–255PubMedCrossRef

Morfeld M, Koch U (2005) Ansprüche an die Evaluation komplexer Gesundheitsprogramme-Disease-Management-Programme in Deutschland. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 99(3):179–184

Robinson R, Steiner A (1998) Managed health care: US evidence and lessons for the National Health Service. Open University Press, Buckingham

Rothe U, Müller G, Schwartz PE, Seifert M, Kunath H, Koch R, Bergmann S, Julius U, Bornstein SR, Hanefeld M, Schulze J (2008) Evaluation of a diabetes management system based on practice guidelines, integrated care and continuous quality management in a federal state of germany: a population-based approach to health care research. Diabetes Care 31:863–868PubMedCrossRef

Saltman R, Otter Cv (1995) Implementing planned markets in health care. Open University Press, Buckingham

Selby JV, Scanlon D, Lafata JE, Villagra V, Beich J, Salber PR (2003) Determining the value of disease management programs. Joint Commission journal on quality and safety 29(9):491–499PubMed

Scheibler F, Pfaff H eds (2004) Shared decision-making: von der Compliance zur partnerschaftlichen Entscheidungsfindung. Hans Huber Verlag, Bern [et al.]

Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R (2002) Does Diabetes Disease Management save money and improve outcomes? Diabetes Care 25 4:684–689CrossRef

Szecsenyi J, Rosemann T, Joos S, Klimm FP, Miksch A (2008) German diabetes disease management programmes are appropriate to restructure care according to the Chronic Care Model. An evaluation with the Patient Assessment of Chronic Illness Care (PACIC-5A) instrument. Diabetes Care 31(6):1150–1154PubMedCrossRef

Schunk M, Schweikert B, Gapp O, Reitmeir P, Meisinger C, Mielck A, Holle R (2007) Zeitliche Veränderungen in Versorgung und Krankheitsmanagement von Diabetes Typ 2 - Patienten zwischen 1997 und 2005. Analyse zweier bevölkerungsbasierter Studien (KORA Augsburg). In: Wichmann H-E, Nowak D, Zapf A, eds. Kongress Medizin und Gesellschaft 2007, Augsburg 17.-21.September 2007, Abstractband. Rheinware Verlag, Mönchengladbach, p 322

SVR (Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen) Kooperation und Verantwortung. Voraussetzungen einer zielorientierten Gesundheitsversorgung. Gutachten 2007

Todd WE, Nash D (eds) (1997) Disease management: a systems approach to improving patient outcomes. American Hospital Pub, Chicago

Ullrich W, Marschall U, Graf C (2007) Versorgungsmerkmale des Diabetes mellitus in Disease-Management-Programmen. Ein Vergleich von in die DMP eingeschriebenen und nichteingeschriebenen Versicherten mit Diabetes. Diabetes, Stoffwechsel und Herz 16:407–414

Veeder NW, Peebles-Wilkins W (2001) Managed care services: policy, programs, and research. Oxford University Press, New York

Wegscheider K, Romes C, Gawlik C (2006) Evaluation von Disease Management Programmen in Deutschland. In: Göpffarth D, Greß S, Jacobs K, Wasem J (eds) 10 Jahre Kassenwahlfreiheit. Jahrbuch Risikostrukturausgleich 2006. Asgard, St. Augustin, pp 261–278

Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A Jr, Ofman JJ (2002) Interventions used in disease management programmes for patients with chronic illness - which one works? Meta-analysis of published reports. Br Med J 325(26):925–927 OctoberCrossRef

Title: Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status
Authors: Thomas Elkeles
Wolf Kirschner
Christian Graf
Petra Kellermann-Mühlhoff
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Journal of Public Health / Issue 3/2009
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-008-0234-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status

Abstract

Aim

Subjects and Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Subjects and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2009

Pilot study: awareness of university students in Jordan of the positive health effects of garlic

Promoting exercise on prescription: recruitment, motivation, barriers and adherence in a Danish community intervention study to reduce type 2 diabetes, dyslipidemia and hypertension

Changes in drug therapy following hospital discharge for patients in a general practice: a German incident study

Katharina Meyer (ed.), Health in Switzerland-The 2008 National Health Report

Clinical pathways – the Bulgarian approach

Patient-based medicine: aligning patients’ perspectives on disease and treatment with evidence-based medicine criteria